圣达生物: 浙江圣达生物药业股份有限公司向特定对象发行A股股票上市公告书

Group 1 - The core point of the announcement is that Zhejiang Shengda Bio-Pharm Co., Ltd. is issuing A-shares to specific investors, with a total of 17,840,666 shares at a price of 15 yuan per share, raising a total of approximately 267.61 million yuan [1][16][18] - The shares will be listed on the Shanghai Stock Exchange after a lock-up period of six months following the issuance [1][21] - The company is a leading supplier of biotin and folic acid, focusing on the research, production, and sales of vitamins, biological preservatives, food additives, and feed additives [9][18] Group 2 - The issuance process included several board meetings and approvals from the shareholders, with the final approval from the China Securities Regulatory Commission (CSRC) received on January 24, 2025 [10][11][19] - The issuance is targeted at specific institutional investors, including private equity funds and asset management companies, ensuring compliance with regulatory requirements [12][31] - The funds raised will be deposited into a dedicated account, and the company has established a three-party supervision agreement to ensure the proper use of the funds [20][21]